That’s good news for the estimated 26 million women in the U.S. who have fibroids — including the millions of Black women who are disproportionately affected by these benign tumors. Black women in the U.S. are up to three times more likely to develop fibroids than white women.
Dr. Elizabeth Stewart, Mayo gynecologist and researcher recently published a review on these approved fibroid medications. They are called oral gonadotropin-releasing hormone (GnRH) antagonist combinations.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: Register at https://newsnetwork.mayoclinic.org/re… to access clean and nat sound versions of this video on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
Mayo Clinic https://mayocl.in/3tNMAdF Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Like Mayo Clinic on Facebook: https://www.facebook.com/ Follow Mayo Clinic on Twitter: https://twitter.com/MayoClinic